The stock of GlaxoSmithKline Pharmaceuticals (GSK Pharma) is down 14 per cent since February, underperforming the BSE Healthcare index, which is up about 5.7 per cent during this period. From its highs in early February, the Indian unit of the pharma multinational has lost a fifth of its market capitalisation (mcap). While a weak December quarter performance and downgrades have led to muted returns, most brokerages have a neutral stance, given the valuation concerns.
Even as top pharmaceutical peers delivered double-digit growth in the December quarter, sales of GSK Pharma, at 805 crore, were flat over the year-ago quarter. They were also less than the ₹860 crore estimated by brokerages.
The flattish revenue was on account of price cuts in key brands and a slowdown in the acute segment. Prices of antibiotic Ceftum and ointment T-Bact were cut by 57 per cent and 30 per cent, respectively, though some of this was offset by volume growth on a sequential basis.
Bu hikaye Business Standard dergisinin April 12, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin April 12, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
Budget likely in 2nd half of July
The Bharatiya Janata Party-led National Democratic Alliance government is hopeful of presenting the full Budget for 2024-25 (FY25) in the second half of July, sources told Business Standard.
'Ease of living': Back in office, Sitharaman lists priorities
Says reforms undertaken since 2014 will continue
Ather plugs into Maha to roll out 1 mn e2Ws a year
To bet ₹1K cr on Aurangabad plant; capacity will hit 1.42 mn
Fire at UP substation trips power supply to parts of Delhi
Outage disrupted day-one ceremony of several ministers
Digital platforms now a crucial pillar for FMCGs to advertise
Digital platforms are a crucial pillar in driving brand imagery, equity, and higher return on investment across categories in the fast-moving consumer goods space, according to a report by Nielsen and Kantar.
Indian varsities can now offer admission twice a year: UGC
Indian universities and higher education institutions will now be allowed to offer admissions twice a year on lines of foreign universities with the University Grants Commission (UGC) giving a go ahead to the plan, UGC chief Jagadesh Kumar said.
SC seeks Centre, NTA reply on fresh NEET-UG exam plea
The Supreme Court on Tuesday sought the response of the Centre and the National Testing Agency on a plea seeking fresh conduct of medical entrance exam NEET-UG, 2024, on the grounds of alleged question paper leak and other malpractices.
IT'S MINNOW OR NEVER
USA's win over Pakistan in the T20 World Cup comes as the icing on a surge of smaller cricket playing nations. Now, how about a dose of Karl Marx?
Hopes of good rains, crop prices fuel rally
The stocks of agrochemical companies have seen a rally ☐ over the past week on expectations that favourable monsoon, higher crop prices and measures taken by the government to boost rural economy would aid the sector.
Sensex, Nifty settle flat amid volatile trade
Benchmark equity indices Sensex and Nifty ended almost flat on Tuesday after a recordbreaking rally as investors preferred to remain on the sidelines awaiting further triggers.
